<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Recash test site | Karlsson Golden | Activity</title>
	<link>https://recash.wpsoul.net/members/songmarch09/activity/</link>
	<atom:link href="https://recash.wpsoul.net/members/songmarch09/activity/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed for Karlsson Golden.</description>
	<lastBuildDate>Fri, 24 Jul 2026 09:11:25 +0000</lastBuildDate>
	<generator>https://buddypress.org/?v=</generator>
	<language>en-US</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
	
						<item>
				<guid isPermaLink="false">5dd42c24d6e2b280053811d87a98bc80</guid>
				<title>Karlsson Golden posted an update: Overall, these findings suggest that the combination therapy [&#133;]</title>
				<link>https://recash.wpsoul.net/activity/p/128333/</link>
				<pubDate>Mon, 30 Dec 2024 11:11:44 +0000</pubDate>

									<content:encoded><![CDATA[<p>Overall, these findings suggest that the combination therapy of ABL001 with paclitaxel or irinotecan would be a better clinical strategy for the treatment of cancer patients.Drug repurposing and drug combination are two strategies that have been widely used to overcome the traditional development of new anticancer drugs. Several FDA-approved drugs&hellip;<span class="activity-read-more" id="activity-read-more-128333"><a href="https://recash.wpsoul.net/activity/p/128333/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">4d9fcace3095c25c9ea68c09882246c4</guid>
				<title>Karlsson Golden became a registered member</title>
				<link>https://recash.wpsoul.net/activity/p/95279/</link>
				<pubDate>Fri, 20 Dec 2024 17:56:50 +0000</pubDate>

				
									<slash:comments>0</slash:comments>
				
							</item>
		
	</channel>
</rss>